Neighbors of proposed Carmel hospital gear up to fight project
More than 100 people gathered Tuesday to plan how to oppose the project, which calls for nine buildings, two helipads and four parking garages.
More than 100 people gathered Tuesday to plan how to oppose the project, which calls for nine buildings, two helipads and four parking garages.
Derica Rice, 53, one of the nation’s most powerful black executives, retired from Indianapolis-based drugmaker Eli Lilly and Co. in December, after the company passed him over when naming a new CEO.
The tool, in this case, is a software platform that will allow certified addiction treatment providers to quickly locate and connect people with available inpatient or residential treatment beds.
Ned Rule, former managing director of investments, claims the Carmel-based developer terminated him without cause to save money during a financial downturn, violating his employment contract.
The company’s board is asking shareholders to support two corporate-governance proposals, including one that would eliminate a requirement that buyout bids garner at least 80 percent shareholder approval.
The House rejected legislation Tuesday that would ease how experimental drugs are provided to people with terminal illnesses.
Health insurer Cigna is buying the nation’s biggest pharmacy benefit manager, the latest in a string of proposed tie-ups as health care’s bill payers attempt to get a grip on rising costs.
The Carmel-based developer and operator of senior care facilities blamed high start-up costs and a challenging reimbursement environment for decision to pull out of Arizona.
FDA Commissioner Scott Gottlieb aimed particular criticism at giant pharmacy benefit managers that contract with health plans to administer coverage of drugs, saying the industry’s tactics have stymied cheaper copies of expensive biotechnology drugs.
The Indiana Legislature on Wednesday sent a bill to Gov. Eric Holcomb's desk that would require medical providers who treat women for complications arising from abortions to report detailed patient information to the state.
Its $1.5 million investment is expected to help B2S Life Sciences more than double its staff and grow its client base, which includes contract research groups, pharmaceutical firms and biotech startups.
The deal includes a portfolio of 545,000 square feet of medical office space in New York, Florida and Canada, occupied by more than 400 physicians’ practices.
Eli Lilly CEO David Ricks’ first year in charge was marked by a wave of activity, including a huge corporate restructuring. The company’s stock price climbed about 6.2 percent during the year.
Since starting a wellness program in 2010, IndyGo has seen employee participation climb from just a few, skeptical workers to 97 percent of the workforce.
Two Los Angeles doctors allegedly used fraudulent studies to persuade people to get Lap-Band surgery for weight loss and duped insurers into helping to pay the bills in what U.S. prosecutors called a $250 million scheme.
American Pain Consortium Holdings LLC, led by Dr. Edward J. Kowlowitz, plans to operate 15 to 20 pain-management practices within three years.
Roche Holding AG—the Basel, Switzerland-based parent of Indianapolis-based Roche Diagnostics—has enlisted a little green gremlin to help rescue its diabetes business after a decade of declining sales.
Dr. Donald Cline, a retired Indianapolis fertility specialist, secretly inseminated dozens of unwitting patients with his own sperm decades ago. Now, many of his offspring are trying to make the most of the long-hidden family ties.
The state’s largest health care system saw gains in admissions, inpatient days and surgeries, but visits to the ER and radiology exams dropped slightly.
Even before news broke that an unidentified health care system had lined up 30 acres at 96th Street and Spring Mill Road for a massive development, projects costing billions of dollars were underway or on the drawing board across the region.